Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
Bruker Corp (NASDAQ: BRKR) closed the day trading at $38.2 up 5.52% from the previous closing price of $36.2. In other words, the price has increased by $5.52 from its previous closing price. On the day, 4.24 million shares were traded. BRKR stock price reached its highest trading level at $38.725 during the session, while it also had its lowest trading level at $36.52.
Ratios:
For a better understanding of BRKR, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 63.00 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 117.56. For the most recent quarter (mrq), Quick Ratio is recorded 0.70 and its Current Ratio is at 1.61. In the meantime, Its Debt-to-Equity ratio is 1.35 whereas as Long-Term Debt/Eq ratio is at 1.32.
On December 19, 2024, Guggenheim started tracking the stock assigning a Buy rating and target price of $72.
On December 10, 2024, UBS started tracking the stock assigning a Neutral rating and target price of $66.UBS initiated its Neutral rating on December 10, 2024, with a $66 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 12 ’25 when Friend Cynthia M sold 3,535 shares for $32.25 per share. The transaction valued at 113,990 led to the insider holds 18,016 shares of the business.
CYNTHIA FRIEND bought 3,535 shares of BRKR for $113,990 on Sep 12 ’25. On Jun 06 ’25, another insider, LAUKIEN FRANK H, who serves as the PRESIDENT & CEO of the company, bought 2,608 shares for $38.36 each. As a result, the insider paid 100,043 and bolstered with 38,462,171 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, BRKR now has a Market Capitalization of 5795679744 and an Enterprise Value of 8237279744. As of this moment, Bruker’s Price-to-Earnings (P/E) ratio for their current fiscal year is 72.91, and their Forward P/E ratio for the next fiscal year is 17.27. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 45.86. For the stock, the TTM Price-to-Sale (P/S) ratio is 1.68 while its Price-to-Book (P/B) ratio in mrq is 3.21. Its current Enterprise Value per Revenue stands at 2.393 whereas that against EBITDA is 14.773.
Stock Price History:
The Beta on a monthly basis for BRKR is 1.22, which has changed by -0.38831067 over the last 52 weeks, in comparison to a change of 0.13033986 over the same period for the S&P500. Over the past 52 weeks, BRKR has reached a high of $64.64, while it has fallen to a 52-week low of $28.53. The 50-Day Moving Average of the stock is 14.74%, while the 200-Day Moving Average is calculated to be -8.44%.
Shares Statistics:
Over the past 3-months, BRKR traded about 4.06M shares per day on average, while over the past 10 days, BRKR traded about 3620330 shares per day. A total of 151.72M shares are outstanding, with a floating share count of 102.94M. Insiders hold about 32.15% of the company’s shares, while institutions hold 82.51% stake in the company. Shares short for BRKR as of 1759190400 were 13008297 with a Short Ratio of 3.20, compared to 1756425600 on 8352956. Therefore, it implies a Short% of Shares Outstanding of 13008297 and a Short% of Float of 18.490000000000002.
Dividends & Splits
BRKR’s forward annual dividend rate is 0.20, up from 0.2 a year ago. Against a Trailing Annual Dividend Yield of 0.0055248616. The stock’s 5-year Average Dividend Yield is 0.31.
Earnings Estimates
As of right now, 12.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is $0.84, with high estimates of $0.92 and low estimates of $0.76.
Analysts are recommending an EPS of between $2.03 and $1.8 for the fiscal current year, implying an average EPS of $1.95. EPS for the following year is $2.27, with 13.0 analysts recommending between $2.67 and $1.75.
Revenue Estimates
11 analysts predict $847.04M in revenue for. The current quarter. It ranges from a high estimate of $854.7M to a low estimate of $838.14M. As of. The current estimate, Bruker Corp’s year-ago sales were $864.4MFor the next quarter, 11 analysts are estimating revenue of $999.73M. There is a high estimate of $1.02B for the next quarter, whereas the lowest estimate is $972.3M.
A total of 11 analysts have provided revenue estimates for BRKR’s current fiscal year. The highest revenue estimate was $3.47B, while the lowest revenue estimate was $3.42B, resulting in an average revenue estimate of $3.44B. In the same quarter a year ago, actual revenue was $3.37BBased on 11 analysts’ estimates, the company’s revenue will be $3.5B in the next fiscal year. The high estimate is $3.55B and the low estimate is $3.45B.
